Galicia Abogados S.C.

Highlighted for its ‘very deep knowledge of current regulations, the sector and its risks’, which thereby allows the eight-strong team to ‘provide practical solutions’, the life sciences practice at Galicia Abogados S.C. is co-led by Bernardo Martínez Negrete and counsel Lisandro Herrera. The group acts for a deep roster of pharmaceutical and healthcare industry clients on matters ranging from logistics and compliance to licenses and dispute resolution. Moreover, as part of a full-service firm the practice has experience throughout the multiple segments that constitute the practice – from issues related to digital health, UNOPS and governmental procurement processes; health care mergers, acquisitions and joint ventures; the regulatory aspects of the release, sale, labelling, promotion, advertising and distribution of medicines, medical devices and human vaccines; along with the drafting and negotiation of agreements and regulatory data protection. Senior figure Martínez-Negrete has been involved in various innovative healthcare projects (not least his advice to Sanofi on the implementation of the first public-private partnership for the manufacturing and commercialisation of influenza vaccines in Mexico), and more recently on projects directly related to Covid-19 and, subsequently, post-pandemic developments; while fellow practice co-head Herrera spent over a decade in house at companies including Sanofi Aventis, Teva and the Asociación Mexicana de Industrias de Investigación Farmacéutica (AMIIF) before moving into private practice and becoming a recognised expert in health regulation, governmental procurement processes, pharmaceutical regulation, medical devices and compliance, among other matters. At associate level,  the experienced Luis Marin Tijerina and younger colleague Martha Contreras advise clients on regulatory matters concerning pharma products, innovative and generic drugs, high-tech equipment, biotechnology, food supplements and medical devices, as well as clinical studies, cosmetics and personal hygiene products, digital health, tobacco products, and toxic and controlled substances. Marin’s practice also takes in consumer protection matters, safety and product liability, and more generally all aspects of the consumer goods sector.